pros and cons of glp-1 medications glp 1 for weight loss In my latest blog, The GLP-1 diabetes and weight-loss drug

Metabolic health and weight loss are more than just calories in and calories spent

Novo Nordisk released Victoza in 2010, then Ozempic in 2017, a once-weekly injection that became a blockbuster

The enzyme dipeptidyl peptidase-4 (DPP-4) rapidly degrades circulating GLP-1, which is why pharmaceutical versions are chemically modified to resist this breakdown and maintain therapeutic levels for extended periods

This content is for informational and educational purposes only and is not intended as medical advice

Low-Frequency and Rare Exome Chip Variants Associate with Fasting Glucose and Type 2 Diabetes Susceptibility. Nature Communications, vol

Conclusion This comprehensive review highlights the therapeutic potential of GLP-1 and its analogs in the management of metabolic disorders, particularly T2DM